It’s not the rogue AI from science fiction that should be keeping industry leaders up at night. It’s the sneakily rapid pace of autonomy that’s happening in their own laboratories. Jared Kaplan, of ...

Over 30 years ago, the two-signal hypothesis for T and B lymphocyte activation was proposed 1. During the last 15 years it has become widely accepted that T cells require two distinct signals for ...

We got to check out Jonathan Blow's Order Of The Sinking Star ahead if The Game Awards premiere and event asked him a few questions.

At ELRIG 2025 Dr Barak Gilboa of Novo Nordisk unveiled a suite of AI-enabled approaches that turn brightfield microscopy from ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

The researchers think the pattern they observed in ants reflects a more universal trend in the evolution of societal ...

Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

Microsoft is killing off an obsolete and vulnerable encryption cipher that Windows has supported by default for 26 years ...

What if we could peer into the brain and watch how it organizes information as we act, perceive, or make decisions? A new ...

Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.